Enzyme Research
New enzyme research from University of Pennsylvania, Medical Department outlined
Published in Cancer Weekly, March 3rd, 2009
In this recently published article, scientists in the United States conducted a study "To evaluate whether two molecular biomarkers, thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD), could be clinically useful in predicting and improving the chemotherapeutic outcome of the oral fluoropyrimidine capecitabine (5'-DFUR or Xeloda (R)), in the treatment of human head and neck squamous cell carcinoma (HNSCC). Quantitative reverse-transcriptase polymerase chain reaction was used to determine the TP and DPD expression levels in different HNSCC cell lines."
"The TP to DPD ratio was calculated and compared to the relative chemosensitivity between cell lines...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-03-03)
More Articles from Cancer Weekly
- Duke University Medical Center
Newly discovered gene could be a prime target in the most lethal brain cancer - AuthorHouse
Nothin' but Try: the Shane Drury Story - Inspirational New Biography Pays Loving Tribute to Professional Bull Rider Shane Drury - Breast Cancer
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer - Cancer Gene Therapy
Data on cancer gene therapy discussed by researchers at Dankook University - Cancer Gene Therapy
Findings from Washington University, Medical Department in cancer gene therapy reported - Cancer Gene Therapy
New cancer gene therapy study findings have been published by scientists at Fourth Military Medical University - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
